Transgene starts 2021 with a new CEO Strasbourg-based Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer. more ➔
Apaxen S.A. appoints CEO Bart Wuurman joined the young Belgian biotechnology company Apaxen S.A. in November as new CEO. more ➔
New at Polyplus-transfection French Polyplus-transfection SA named Mario Philips as new CEO. He succeeds Karsten Wilking, now a Strategic Advisor of the biotech company, specialist for innovative transfection solutions to support … more ➔
Management changes at BioChek Thomas Struckmeyer will join the BioChek Group based in Reeuwijk as new CEO from mid-December. He succeeds Barend van Dam, who will assume the position of CEO of the BioChek Group. more ➔
New Director General of EuropaBio Claire Skentelbery, well known and connected in the European biotech community, will be the new Director General of EuropaBio. She will join the EuropaBio team at the end of November. more ➔
ELRIG keeping connected Melanie Leveridge takes over the lead of the European Laboratory Research & Innovation Group (ELRIG) UK to drive further collaboration between academia and biopharma industry. more ➔
Redx appoints new CMO In March 2021, Dr Jane Robertson will take over the position of Chief Medical Officer at Redx Pharma Plc in Alderley Park. more ➔
Valneva is looking for a new CFO David Lawrence, Chief Financial Officer of French Valneva, will retire at the end of 2020. more ➔
MiNA Therapeutics with new CBO Peter Bains started at MiNA Therapeutics as new Chief Business Officer at the end of September. more ➔
New on Vifor Pharma boardSince September Gregory Oakes is a new Member of the Vifor Management Board and President North America of the Swiss pharmaceutical company. more ➔
